Japan · Delayed Price · Currency is JPY Kaken Pharmaceutical Statistics
Total Valuation
TYO:4521 has a market cap or net worth of JPY 159.43 billion. The enterprise value is 117.44 billion.
| Market Cap | 159.43B |
| Enterprise Value | 117.44B |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
TYO:4521 has 37.87 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 37.87M |
| Shares Outstanding | 37.87M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 5.01% |
| Owned by Institutions (%) | 27.80% |
| Float | 32.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 68.08 |
| PS Ratio | 2.11 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -30.65 |
| EV / Sales | 1.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.09, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.09 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -93.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.86% |
| Return on Capital Employed (ROCE) | -2.51% |
| Weighted Average Cost of Capital (WACC) | 4.50% |
| Revenue Per Employee | 67.20M |
| Profits Per Employee | -3.40M |
| Employee Count | 1,126 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -770.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.71% in the last 52 weeks. The beta is 0.06, so TYO:4521's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -0.71% |
| 50-Day Moving Average | 4,043.20 |
| 200-Day Moving Average | 3,875.17 |
| Relative Strength Index (RSI) | 64.30 |
| Average Volume (20 Days) | 144,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:4521 had revenue of JPY 75.66 billion and -3.83 billion in losses. Loss per share was -100.31.
| Revenue | 75.66B |
| Gross Profit | 40.17B |
| Operating Income | -3.83B |
| Pretax Income | -4.60B |
| Net Income | -3.83B |
| EBITDA | -1.43B |
| EBIT | -3.83B |
| Loss Per Share | -100.31 |
Balance Sheet
The company has 45.84 billion in cash and 3.85 billion in debt, with a net cash position of 41.99 billion or 1,108.79 per share.
| Cash & Cash Equivalents | 45.84B |
| Total Debt | 3.85B |
| Net Cash | 41.99B |
| Net Cash Per Share | 1,108.79 |
| Equity (Book Value) | 145.81B |
| Book Value Per Share | 3,850.39 |
| Working Capital | 72.91B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -5.06% |
| Pretax Margin | -6.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 190.00, which amounts to a dividend yield of 4.50%.
| Dividend Per Share | 190.00 |
| Dividend Yield | 4.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 4.52% |
| Earnings Yield | -2.40% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 28, 2015. It was a reverse split with a ratio of 0.5.
| Last Split Date | Sep 28, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |